Insiders · KALV

Christopher Yea

Chief Development Officer at KalVista Pharmaceuticals, Inc. (KALV)

Christopher Yea has filed 41 insider reports with the SEC since February 2021, as chief Development Officer at KalVista Pharmaceuticals, Inc. (KALV). In the last 12 months Christopher Yea sold $1.19M of stock on the open market. In the latest filing, on May 29, 2026, Christopher Yea sold 33,800 shares of KalVista Pharmaceuticals, Inc. (KALV) for $905K at an average of $26.78.

Filings
41
Companies
1
Bought on market
None
Sold on market
$4.05M

Companies where Christopher Yea is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
KalVista Pharmaceuticals, Inc. logo
KALV
KalVista Pharmaceuticals, Inc.
Chief Development Officer229,918$4.05MMay 29, 2026

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare Christopher Yea with

Other insiders at the same companies

Questions about Christopher Yea

What is Christopher Yea's role at KalVista Pharmaceuticals, Inc.?
Christopher Yea reports to the SEC as chief Development Officer at KalVista Pharmaceuticals, Inc. (KALV), according to the latest filing on May 29, 2026.
How many shares does Christopher Yea own?
After the latest filing that states it, Christopher Yea directly owned 229,918 shares of KalVista Pharmaceuticals, Inc. (KALV). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Christopher Yea bought or sold stock recently?
The most recent open-market sale was on May 27, 2026: sold 33,800 shares of KalVista Pharmaceuticals, Inc. (KALV) for $905K at an average of $26.78.
How do I get alerts when Christopher Yea files?
Follow Christopher Yea on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Christopher Yea (SEC CIK 0001691102). Totals count each trade once, skipping amendments whose original is on file, from Feb 9, 2021 on. View on SEC EDGAR · Get this as JSON